Impact of nomenclature as metabolic associated steatotic liver disease on steatotic liver disease prevalence and screening: a prospective population survey in Asians

被引:6
|
作者
Wu, Tingfeng [1 ,5 ]
Ye, Junzhao [1 ]
Mo, Suilin [2 ,5 ]
Ye, Miaosheng [6 ]
Li, Xiaoyi [8 ]
Li, Qing [7 ]
Wang, Wengeng [10 ]
Zheng, Qiaocong [10 ,11 ]
Luo, Ke [9 ]
Zhang, Yi [14 ]
Tu, Shouwei [15 ]
Che, Daituan [12 ,16 ]
Gong, Rulong [12 ]
Chen, Xing [13 ]
Miu, Rong [3 ]
Shao, Congxiang [1 ]
Sun, Yanhong [4 ]
Zhong, Bihui [1 ]
机构
[1] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Gastroenterol, 58 Zhongshan II Rd, Guangzhou 510080, Peoples R China
[2] Sun Yat Sen Univ, Affiliated Hosp 1, Hlth Care Ctr, Guangzhou, Peoples R China
[3] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Hlth Care Ctr Huangpu, Guangzhou, Peoples R China
[4] Sun Yat Sen Univ, Affiliated Hosp 1, Clin Labs, Guangzhou, Peoples R China
[5] Guangzhou Univ Tradit Chinese Med, Foshan Hosp Tradit Chinese Med, Dept Gastroenterol, Guangzhou, Peoples R China
[6] Guangdong Prov Peoples Hosp, Pingzhou Hosp, Dept Hlth Care Ctr, Guangzhou, Peoples R China
[7] South China Univ Technol, Nanhai Peoples Hosp, Dept Hlth Care Ctr, Foshan, Peoples R China
[8] Yunfu Peoples Hosp, Dept Hlth Care Ctr, Yunfu, Peoples R China
[9] Luoding Peoples Hosp, Dept Hlth Care Ctr, Yunfu, Peoples R China
[10] Lianzhou Peoples Hosp, Dept Hlth Care Ctr, Qingyuan, Peoples R China
[11] Yangjiang Peoples Hosp, Dept Hlth Care Ctr, Yangjiang, Peoples R China
[12] Yangdong Peoples Hosp, Dept Hlth Care Ctr, Yangjiang, Peoples R China
[13] Yangjiang Publ Hlth Hosp, Dept Hepatol, Yangjiang, Peoples R China
[14] Jieyang Peoples Hosp, Dept Hlth Care Ctr, Jieyang, Peoples R China
[15] Ruyuan Peoples Hosp, Dept Hlth Care Ctr, Shaoguan, Peoples R China
[16] Cent Peoples Hosp Zhanjiang, Dept Hlth Care Ctr, Zhanjiang, Peoples R China
基金
中国国家自然科学基金;
关键词
metabolic associated fatty liver disease; nonalcoholic fatty liver disease; prevalence; steatotic liver disease; FATTY; MAFLD; NAFLD;
D O I
10.1111/jgh.16554
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background and Aim: The introduction of the latest nomenclature, metabolic associated steatotic liver disease (MASLD), proposed by the multi-society without Asian society consensus statement, aims to redefine the diagnostic criteria for metabolic associated fatty liver disease (MAFLD). However, its effect on the epidemiology in Asia remains unclear. Method: We conducted a population-based cross-sectional survey on fatty liver disease using multistage stratified random sampling of participants from Guangzhou, a representative area in China (ChiCTR2000033376). Demographic, socioeconomic, lifestyle, and laboratory data were collected. Hepatic steatosis and the severity of fibrosis were assessed using FibroScan. Results: A total of 7388 individuals were recruited, the proportion of which meeting the definitions for nonalcoholic fatty liver disease (NAFLD), MAFLD, and MASLD were 2359 (31.9%), 2666 (36.1%), and 2240 (30.3%), respectively. One hundred and twenty (1.6%) patients had cryptogenic SLD, and 537 (7.3%) patients were diagnosed with MetALD. MASLD did not significantly differ from NAFLD and MAFLD, except that MAFLD patients had a lower proportion of males, hypertension, and diabetes and were less likely to consume tea (P < 0.05). Both cryptogenic SLD and MASLD non-MAFLD patients exhibited milder hepatic steatosis and a lower frequency of liver injury than NAFLD, MAFLD, or MASLD patients (all P < 0.05). An increased HOMA-IR (adjusted OR: 1.33, 95% CI: 1.10-2.03) was associated with higher risk of moderate-to-severe steatosis for MASLD non-MAFLD patients, while consuming more cups of tea (P for trend = 0.015) showed inverse associations. Conclusion: Irrespective of terminology used is that fatty liver disease is highly prevalent in the Han Chinese population. Differences in insulin resistance and lifestyle risk factors are associated with redefinition disparities.
引用
收藏
页码:1636 / 1647
页数:12
相关论文
共 50 条
  • [1] Implications of the new nomenclature of steatotic liver disease and definition of metabolic dysfunction-associated steatotic liver disease
    Loomba, Rohit
    Wong, Vincent Wai-Sun
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2024, 59 (02) : 150 - 156
  • [2] PREVALENCE OF STEATOTIC LIVER DISEASE IN THE US USING THE NEW NOMENCLATURE
    Sedki, Mai
    Mannalithara, Ajitha
    Kwong, Allison J.
    Chung, Nakia
    Charu, Vivek
    Sripongpun, Pimsiri
    Kim, W. Ray
    GASTROENTEROLOGY, 2024, 166 (05) : S1634 - S1634
  • [3] PREVALENCE AND SEVERITY OF METABOLIC ASSOCIATED STEATOTIC LIVER DISEASE AND FIBROSIS IN POPULATION SCREENING WITH VIBRATION CONTROLLED TRANSIENT ELASTOGRAPHY
    Zhu, Kai
    Bedi, Harjot
    Chahal, Daljeet
    Yoshida, Eric M.
    Kwan, Peter
    GASTROENTEROLOGY, 2024, 166 (05) : S477 - S477
  • [4] A New Korean Nomenclature for Steatotic Liver Disease
    KOREAN JOURNAL OF GASTROENTEROLOGY, 2024, 84 (01): : 1 - 2
  • [6] Metabolic Dysfunction-Associated Steatotic Liver Disease
    Ali, Sajjadh M. J.
    Lai, Michelle
    ANNALS OF INTERNAL MEDICINE, 2025, 178 (01) : ITC1 - ITC17
  • [7] Prevalence of Metabolic-Associated Steatotic Liver Disease in Patients With Primary Aldosteronism
    Tizianel, Irene
    Madinelli, Alberto
    Crimi, Filippo
    Barbot, Mattia
    Censi, Simona
    Sabbadin, Chiara
    Ceccato, Filippo
    CLINICAL ENDOCRINOLOGY, 2025,
  • [8] Steatotic Liver Disease with metabolic Dysfunction - the new Nomenclature for Fatty Liver in the German Context
    Schattenberg, Joern M.
    Tacke, Frank
    ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2024, 62 (07): : 1074 - 1076
  • [9] Prevalence and Risk Factors of Metabolic Dysfunction-associated Steatotic Liver Disease
    Plaza-Aulestia, Nahia
    Ibarguengoitia-Barrena, Oihane
    Sampedro-Andrada, Blanca
    Juan-Lopez, Cristina San
    Morillo-Montanes, Victoria
    Urionaguena, Irati
    Calvo, Itziar
    Seisdedos, David Montero
    Vega-Alvarez, Lucia
    Llorente, Jose Francisco Garcia
    Revenga, Nuria Vegas
    ARTHRITIS & RHEUMATOLOGY, 2024, 76 : 4669 - 4671
  • [10] Embracing Change: From Nonalcoholic Fatty Liver Disease to Metabolic Dysfunction-Associated Steatotic Liver Disease Under the Steatotic Liver Disease Umbrella
    Noureddin, Mazen
    Wei, Lai
    Castera, Laurent
    Tsochatzis, Emmanuel A.
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2024, 22 (01) : 9 - 11